Testimonial - Refractive Anaemia

A 69 year old female with severe neutropenia as a component of pancytopenia associated with refractive anaemia with excess blasts II (myelodysplastic syndrome) found that her neutrophil count had risen from 8.8 to 31.8% (and her monocytes rose from 1.5% to 5%) over 2 weeks following NIS treatment.

Only a couple of weeks earlier her doctor gloomily announced that any infection would be her last, and that there was nothing more medicine could do for her. When the doctor received her last blood test results, he made a statement to the effect that there had been a mistake and that it wasn’t her results and sent her off for another blood test. The subsequent blood test confirmed the results of the first blood test, and in doing so, confirmed that NIS had indeed been successful in stimulating bone marrow myeloid recovery. Medically, there is no known effective treatment for MDS in a patient > 60 years old.

“MDS is a bone marrow stem cell disorder resulting in ineffective hematopoiesis manifested by irreversible quantitative and qualitative defects in hematopoietic cells…the course of the disease is chronic with gradually worsening cytopenias due to progressive bone marrow failure. Approximately one-third of patients with MDS will progress to an atypical form of AML…a form of leukaemia that is notoriously resistant to treatment… about 50% of deaths occur as a result of bleeding or infection.”


Submitted by: Rodney Mason
SA, Australia